Clinical trial

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)

NCT03658967

Study summary

ClinicalTrials.gov

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Lymfactin® (1x10E11 vp) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-06-07

PhasePHASE2

Conditions

Secondary Lymphedemaunresolved

Interventions

Lymfactin® (1x10E11 vp)DRUG

PlaceboDRUG

Sponsors & collaborators

Herantis Pharma Plc.lead sponsor

Mapped research locations

StockholmSweden1 HelsinkiFinland1 UppsalaSweden1 TurkuFinland1 TampereFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03658967 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.